中国中医药信息杂志
中國中醫藥信息雜誌
중국중의약신식잡지
CHINESE JOURNAL OF INFORMATION ON TRADITIONAL CHINESE MEDICINE
2015年
1期
53-57
,共5页
方吕贵%饶向荣%李深%王丽%卢建新%吴玲艳%刘畅
方呂貴%饒嚮榮%李深%王麗%盧建新%吳玲豔%劉暢
방려귀%요향영%리심%왕려%로건신%오령염%류창
动脉粥样硬化性肾动脉狭窄%缓衰口服液%肾间质纤维化%低氧%小鼠
動脈粥樣硬化性腎動脈狹窄%緩衰口服液%腎間質纖維化%低氧%小鼠
동맥죽양경화성신동맥협착%완쇠구복액%신간질섬유화%저양%소서
atherosclerosis renal artery stenosis%Huanshuai Oral Liquid%renal interstitial fibrosis%hypoxia%mice
目的:探讨缓衰口服液对动脉粥样硬化性肾动脉狭窄(ARAS)小鼠肾脏低氧-微血管荒废-肾间质纤维化病理过程的影响机制。方法通过对ApoE-/-小鼠喂以高脂饲料,并行左侧肾脏切除术,建立ARAS动物模型。手术2周后,将模型小鼠随机分为缓衰口服液组(中药组)、模型组,另设空白组(C57BL/6J小鼠)。中药组用缓衰口服液0.01 mL/(g?d)灌胃,空白组和模型组予0.01 mL/(g?d)生理盐水灌胃。给药12周后,取材,检测肾功能,Masson 染色观察肾间质纤维化程度,免疫组化法检测各组小鼠肾脏Ⅳ型胶原、α-平滑肌肌动蛋白(α- SMA)、血管性血友病因子(vWF)的表达,RT-PCR检测低氧诱导因子-1α(HIF-1α)和转化生长因子-β(TGF-β)的表达情况。结果与空白组比较,模型组小鼠肾功能不全明显,肾动脉狭窄严重,肾间质纤维化明显,HIF-1α、TGF-β、Ⅳ型胶原和α-SMA 表达明显增加(P<0.05),vWF 表达明显减少(P<0.05);与模型组比较,中药组HIF-1α、TGF-β、Ⅳ型胶原和α-SMA表达明显减少(P<0.05),vWF表达明显增加(P<0.05)。结论缓衰口服液对ARAS小鼠的肾功能和肾间质纤维化有明显改善作用,该作用可能与其对缺血性肾脏HIF-1α和TGF-β表达的抑制有关。
目的:探討緩衰口服液對動脈粥樣硬化性腎動脈狹窄(ARAS)小鼠腎髒低氧-微血管荒廢-腎間質纖維化病理過程的影響機製。方法通過對ApoE-/-小鼠餵以高脂飼料,併行左側腎髒切除術,建立ARAS動物模型。手術2週後,將模型小鼠隨機分為緩衰口服液組(中藥組)、模型組,另設空白組(C57BL/6J小鼠)。中藥組用緩衰口服液0.01 mL/(g?d)灌胃,空白組和模型組予0.01 mL/(g?d)生理鹽水灌胃。給藥12週後,取材,檢測腎功能,Masson 染色觀察腎間質纖維化程度,免疫組化法檢測各組小鼠腎髒Ⅳ型膠原、α-平滑肌肌動蛋白(α- SMA)、血管性血友病因子(vWF)的錶達,RT-PCR檢測低氧誘導因子-1α(HIF-1α)和轉化生長因子-β(TGF-β)的錶達情況。結果與空白組比較,模型組小鼠腎功能不全明顯,腎動脈狹窄嚴重,腎間質纖維化明顯,HIF-1α、TGF-β、Ⅳ型膠原和α-SMA 錶達明顯增加(P<0.05),vWF 錶達明顯減少(P<0.05);與模型組比較,中藥組HIF-1α、TGF-β、Ⅳ型膠原和α-SMA錶達明顯減少(P<0.05),vWF錶達明顯增加(P<0.05)。結論緩衰口服液對ARAS小鼠的腎功能和腎間質纖維化有明顯改善作用,該作用可能與其對缺血性腎髒HIF-1α和TGF-β錶達的抑製有關。
목적:탐토완쇠구복액대동맥죽양경화성신동맥협착(ARAS)소서신장저양-미혈관황폐-신간질섬유화병리과정적영향궤제。방법통과대ApoE-/-소서위이고지사료,병행좌측신장절제술,건립ARAS동물모형。수술2주후,장모형소서수궤분위완쇠구복액조(중약조)、모형조,령설공백조(C57BL/6J소서)。중약조용완쇠구복액0.01 mL/(g?d)관위,공백조화모형조여0.01 mL/(g?d)생리염수관위。급약12주후,취재,검측신공능,Masson 염색관찰신간질섬유화정도,면역조화법검측각조소서신장Ⅳ형효원、α-평활기기동단백(α- SMA)、혈관성혈우병인자(vWF)적표체,RT-PCR검측저양유도인자-1α(HIF-1α)화전화생장인자-β(TGF-β)적표체정황。결과여공백조비교,모형조소서신공능불전명현,신동맥협착엄중,신간질섬유화명현,HIF-1α、TGF-β、Ⅳ형효원화α-SMA 표체명현증가(P<0.05),vWF 표체명현감소(P<0.05);여모형조비교,중약조HIF-1α、TGF-β、Ⅳ형효원화α-SMA표체명현감소(P<0.05),vWF표체명현증가(P<0.05)。결론완쇠구복액대ARAS소서적신공능화신간질섬유화유명현개선작용,해작용가능여기대결혈성신장HIF-1α화TGF-β표체적억제유관。
Objective To explore the mechanism ofHuanshuai Oral Liquid in the process of hypoxia-microvascular waste-renal interstitial fibrosis in mice with atherosclerosis renal artery stenosis.Methods The atherosclerosis renal artery stenosis model was established on Apoe-/- mice by high fat feed and uninephrectomy. After 2 weeks of renal ablation, model mice were randomly divided into TCM group (Huanshuai Oral Liquid) and model group. C57BL/6J mice were taken as the blank group. The mice of TCM group receivedHuanshuai Oral Liquid 0.01 mL/(g?d) for gavage, while the blank group and the model group received normal saline 0.01 mL/(g?d) for gavage. Renal function, atherosclerosis and renal interstitial fibrosis were assessed in the 12th week after taking medicine via immunohistochemical method to detect the expressions of the collagen typeⅣ, alpha smooth muscle actin (α-SMA) andⅧ factor related antigen (vWF), and via RT-PCR to detect the expressions of HIF-1α and TGF-β.ResultsCompared with the blank group, the model group suffered severe renal artery stenosis and renal fibrosis, and the expressions of HIF-1α, TGF-β, collagen typeⅣ andα-SMA significantly increased (P<0.05), while the expression of vWF decreased (P<0.05). Compared with the model group, the expressions of HIF-1α, TGF-β, collagen typeⅣ andα-SMA group, the expressions of HIF-1α, TGF-β, collagen typeⅣ andα-SMA significantly decreased in the TCM group (P<0.05), while the expression of vWF significantly increased (P<0.05).ConclusionHuanshuai Oral Liquid could significantly improve the renal function and the renal tubular-interstitial fibrosis. The mechanism might be associated with regulating the expressions of HIF-1α and TGF-β.